Pioglitazone News and Research

RSS
NAC amino acid may offer new treatment options for psychiatric disorders

NAC amino acid may offer new treatment options for psychiatric disorders

Study finds that triple therapy corrects two core defects in type 2 diabetes

Study finds that triple therapy corrects two core defects in type 2 diabetes

Drug used to control Type II diabetes can help repair spinal cords of mice suffering from inherited disease

Drug used to control Type II diabetes can help repair spinal cords of mice suffering from inherited disease

IDIBELL signs patent licensing agreement with Minoryx

IDIBELL signs patent licensing agreement with Minoryx

Eli Lilly reports positive results from Phase III AWARD trials of type 2 diabetes drug, dulaglutide

Eli Lilly reports positive results from Phase III AWARD trials of type 2 diabetes drug, dulaglutide

Invokana tablets receive FDA approval to treat adults with type 2 diabetes

Invokana tablets receive FDA approval to treat adults with type 2 diabetes

FDA grants final approval to Breckenridge’s Pioglitazone Hydrochloride ANDA

FDA grants final approval to Breckenridge’s Pioglitazone Hydrochloride ANDA

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

Takeda receives FDA approval for Nesina, Kazano and Oseni to treat type 2 diabetes

Takeda receives FDA approval for Nesina, Kazano and Oseni to treat type 2 diabetes

Lilly, Boehringer Ingelheim announce top-line results from empagliflozin Phase III trials on T2D

Lilly, Boehringer Ingelheim announce top-line results from empagliflozin Phase III trials on T2D

FDA approves Watson’s generic Actos

FDA approves Watson’s generic Actos

Common diabetes treatment may cause bladder cancer

Common diabetes treatment may cause bladder cancer

Teva launches generic ACTOplus met to improve glucose control in adults with type 2 diabetes

Teva launches generic ACTOplus met to improve glucose control in adults with type 2 diabetes

Mylan Pharmaceuticals receives FDA approval for pioglitazone tablets to treat type 2 diabetes

Mylan Pharmaceuticals receives FDA approval for pioglitazone tablets to treat type 2 diabetes

Lilly, Boehringer Ingelheim receive FDA approval for Tradjenta sNDA to treat type 2 diabetes

Lilly, Boehringer Ingelheim receive FDA approval for Tradjenta sNDA to treat type 2 diabetes

Ranbaxy’s generic pioglitazone hydrochloride tablets now available in the U.S.

Ranbaxy’s generic pioglitazone hydrochloride tablets now available in the U.S.

Study: Diabetes drugs increase patients' risk of bladder cancer

Study: Diabetes drugs increase patients' risk of bladder cancer

Popular class of diabetes drugs increase risk for bladder cancer

Popular class of diabetes drugs increase risk for bladder cancer

Scientists decipher molecular causes of life-threatening candida fungal infections

Scientists decipher molecular causes of life-threatening candida fungal infections

Takeda resubmits alogliptin and fixed-dose combination therapy NDAs with FDA

Takeda resubmits alogliptin and fixed-dose combination therapy NDAs with FDA